| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 山东赛托生物科技股份有限公司创建于2010年，以甾体药物中间体研发和生产为主营业务，2017年在深交所成功上市，占地940余亩。 公司立足于生物制药的前沿领域，历经多年的自主研发和技术引进，率先实现了生物制药技术在甾体药物领域的规模化应用，是一家应用基因工程技术及微生物转化技术，专业从事新型甾体类原料药物研发、生产为一体的生物医药高新技术企业。 公司坚持科技创新路线，与国内多家知名高端科研院校保持长期而良好的合作关系；建有山东省重点工程实验室一座；从基础研究到应用研究，通过自主研发、科研机构合作、聘请国内外行业专家等多种方式，建立了国内一条全系列甾体产品生产线；累计申请各项知识产权30项，其中已授权19项，年均研发项目保持5个以上。 公司坚持用国际化标准管理体系来推进公司的各项管理工作，先后通过ISO90001质量管理体系、ISO14000环境管理体系、ISO18000安全卫生管理体系、ISO50001能源管理体系等认证。 发展至今，公司已完成从甾体药物基础原料到终端制剂的全产业链布局。未来，公司将继续秉承诚实守信、务实创新、和谐共赢的价值理念，打造集医药中间体、原料药和成品制剂为一体的生物技术企业。 | ||||||||||||||||||||||||
| Main Business | 应用基因工程技术和微生物转化技术研发与生产甾体药物原料 | ||||||||||||||||||||||||
| Legal Representative | 米奇 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 李璐 | ||||||||||||||||||||||||
| Solicitors | 国浩律师（杭州）事务所 | ||||||||||||||||||||||||
| Auditors | 天健会计师事务所（特殊普通合伙）;立信中联会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0530-2263536 | ||||||||||||||||||||||||
| Fax No | 0530-2263536 | ||||||||||||||||||||||||
| Website | www.sitobiotech.com | ||||||||||||||||||||||||
| stock@sitobiotech.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 06/01/2017 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.250 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.450 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 10.607 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 4.214B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |